Lista de obras - Magnus Sjogren - Dominio Público Uruguay

A new putative principle for diagnosis of Creutzfeldt-Jakob disease

artículo científico publicado en 2002

A new rating scale for age-related white matter changes applicable to MRI and CT.

artículo científico publicado en 2001

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers.

artículo científico publicado en 2014

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

artículo científico publicado en 2003

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

artículo científico publicado en 2004

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

artículo científico publicado en 2003

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

artículo científico publicado en 2015

Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia

artículo científico publicado en 2010

Biological correlates of clinical subgroups of Alzheimer's disease

artículo científico publicado en 2002

Both total and phosphorylated tau are increased in Alzheimer's disease

artículo científico publicado en 2001

CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC).

artículo científico publicado en 2010

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

artículo científico publicado en 2000

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42 ⬇️

artículo científico publicado el 1 de octubre de 2003

Case report: cognitive performance in an extreme case of anorexia nervosa with a body mass index of 7.7.

artículo científico publicado en 2020

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports ⬇️

artículo científico publicado el 24 de febrero de 2010

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

artículo científico publicado en 2009

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia

artículo científico publicado en 2001

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

artículo científico publicado en 1995

Cholesterol and Alzheimer's disease--is there a relation?

artículo científico publicado en 2005

Classification and subtypes of vascular dementia

artículo científico publicado en 2003

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations

artículo científico publicado en 2001

Cognitive improvement following weight gain in patients with anorexia nervosa: A systematic review

scientific article published on 12 October 2020

Comorbid depression as a negative predictor of weight gain during treatment of anorexia nervosa: A systematic scoping review

artículo científico publicado en 2020

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

artículo científico publicado en 2000

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

artículo científico publicado en 2002

Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia ⬇️

artículo científico publicado el 1 de enero de 2003

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

artículo científico publicado en 2004

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

artículo científico publicado en 1998

Depressive symptoms and white matter changes in patients with dementia

artículo científico publicado en 2006

Developing novel blood-based biomarkers for Alzheimer's disease

artículo científico publicado en 2014

Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly.

artículo científico publicado en 2014

Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

artículo científico

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

artículo científico publicado en 2004

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.

artículo científico publicado en 2000

Frontotemporal dementia--a brief review.

artículo científico publicado en 2005

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence

artículo científico publicado en 2011

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

artículo científico publicado en 2003

HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression

artículo científico publicado en 2004

High total cholesterol levels in late life associated with a reduced risk of dementia.

artículo científico publicado en 2005

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

article

Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications

artículo científico publicado en 2004

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

scientific article published on 01 March 2002

Increased lipid and lipoprotein concentrations in anorexia nervosa: A systematic review and meta-analysis

scientific article published on 28 March 2019

Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness.

artículo científico publicado en 2003

Longitudinal EEG findings in dementia related to the parietal brain syndrome and the degree of dementia.

artículo científico publicado en 1998

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

artículo científico publicado en 2001

Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.

artículo científico publicado en 2006

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

artículo científico publicado en 2003

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

artículo científico publicado en 2008

Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.

artículo científico publicado en 2018

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

artículo científico publicado en 2001

Neurofilament protein levels in CSF are increased in dementia.

artículo científico publicado en 1999

Objective measurement of the alertness level in dementia

artículo científico publicado en 2003

Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.

artículo científico publicado en 2001

Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study

artículo científico publicado en 2013

Prodromal cognitive signs of dementia in 85-year-olds using four sources of information.

artículo científico publicado en 2005

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

artículo científico publicado en 2002

Proteome studies of CSF in AD patients.

artículo científico publicado en 2005

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

artículo científico publicado en 2000

Relationship between depressive symptomatology and the subcortical brain syndrome in dementia

artículo científico publicado en 2002

Secular changes in cognitive predictors of dementia and mortality in 70-year-olds

artículo científico publicado en 2010

Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.

artículo científico publicado en 2003

Sexual function and dysfunction among women with anorexia nervosa: A systematic scoping review

scientific article published on 25 May 2020

Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.

artículo científico publicado en 2008

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

artículo científico publicado en 1996

Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

artículo científico publicado en 2008

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

artículo científico publicado en 2002

Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome ⬇️

artículo científico publicado el 1 de junio de 1997

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

scientific article published on 01 January 2000

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

artículo científico publicado en 2001

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

artículo científico publicado en 2001

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

artículo científico publicado en 2005

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

artículo científico publicado en 1997

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

artículo científico publicado en 2005

The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type

artículo científico publicado en 2001

The future of blood-based biomarkers for Alzheimer's disease

artículo científico publicado en 2013

The link between cholesterol and Alzheimer's disease

artículo científico publicado en 2005

The pattern of cognitive symptoms predicts time to dementia onset

artículo científico publicado en 2009

The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds.

artículo científico publicado en 2003

The use of indexes in the interpretation of cerebrospinal fluid analyses

artículo científico publicado en 2010

The use of proteomics in biomarker discovery in neurodegenerative diseases

artículo científico publicado en 2005

Treatment of Alzheimer's disease with clioquinol

artículo científico publicado en 2001

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein

artículo científico publicado en 2003

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

artículo científico publicado en 2004

Lista de obras de Magnus Sjogren

A new putative principle for diagnosis of Creutzfeldt-Jakob disease

A new rating scale for age-related white matter changes applicable to MRI and CT.

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers.

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia

Biological correlates of clinical subgroups of Alzheimer's disease

Both total and phosphorylated tau are increased in Alzheimer's disease

CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC).

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42 ⬇️

Case report: cognitive performance in an extreme case of anorexia nervosa with a body mass index of 7.7.

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports ⬇️

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

Cholesterol and Alzheimer's disease--is there a relation?

Classification and subtypes of vascular dementia

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations

Cognitive improvement following weight gain in patients with anorexia nervosa: A systematic review

Comorbid depression as a negative predictor of weight gain during treatment of anorexia nervosa: A systematic scoping review

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia ⬇️

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

Depressive symptoms and white matter changes in patients with dementia

Developing novel blood-based biomarkers for Alzheimer's disease

Effect of diagnostic criteria on prevalence of frontotemporal dementia in the elderly.

Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.

Frontotemporal dementia--a brief review.

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression

High total cholesterol levels in late life associated with a reduced risk of dementia.

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

Increased lipid and lipoprotein concentrations in anorexia nervosa: A systematic review and meta-analysis

Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness.

Longitudinal EEG findings in dementia related to the parietal brain syndrome and the degree of dementia.

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

Neurofilament protein levels in CSF are increased in dementia.

Objective measurement of the alertness level in dementia

Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.

Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study

Prodromal cognitive signs of dementia in 85-year-olds using four sources of information.

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

Proteome studies of CSF in AD patients.

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

Relationship between depressive symptomatology and the subcortical brain syndrome in dementia

Secular changes in cognitive predictors of dementia and mortality in 70-year-olds

Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.

Sexual function and dysfunction among women with anorexia nervosa: A systematic scoping review

Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome ⬇️

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type

The future of blood-based biomarkers for Alzheimer's disease

The link between cholesterol and Alzheimer's disease

The pattern of cognitive symptoms predicts time to dementia onset

The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds.